Cargando…

Evaluation of Medicine Information Leaflets for Omeprazole, Safety Knowledge, and Perceptions of Taking the Medication in Thailand

PURPOSE: This study aimed to compare package inserts and patient information leaflets for omeprazole in terms of the quality of and satisfaction with the written medicine information, medication safety knowledge, and perceived benefits and risks. PATIENTS AND METHODS: A cross-sectional, comparative...

Descripción completa

Detalles Bibliográficos
Autores principales: Wongtaweepkij, Kamonphat, Sup-adulchai, Nutchwarang, Chanachoat, Jirath, Krska, Janet, Jarernsiripornkul, Narumol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064870/
https://www.ncbi.nlm.nih.gov/pubmed/37009429
http://dx.doi.org/10.2147/PPA.S397557
_version_ 1785017985541341184
author Wongtaweepkij, Kamonphat
Sup-adulchai, Nutchwarang
Chanachoat, Jirath
Krska, Janet
Jarernsiripornkul, Narumol
author_facet Wongtaweepkij, Kamonphat
Sup-adulchai, Nutchwarang
Chanachoat, Jirath
Krska, Janet
Jarernsiripornkul, Narumol
author_sort Wongtaweepkij, Kamonphat
collection PubMed
description PURPOSE: This study aimed to compare package inserts and patient information leaflets for omeprazole in terms of the quality of and satisfaction with the written medicine information, medication safety knowledge, and perceived benefits and risks. PATIENTS AND METHODS: A cross-sectional, comparative study was conducted at a university hospital in Thailand. Outpatients visiting the pharmacy departments prescribed omeprazole were randomly selected to receive either a package insert or a patient information leaflet. Medication safety knowledge was measured using a set of eight questions. The quality of the written medicine information was measured by the Consumer Information Rating Form. Perceived benefits and risks of the medication were rated using a visual analog scale. Linear regression was used to determine factors associated with perceived benefits and risks. RESULTS: Of the 645 patients, 293 agreed to answer the questionnaire. 157 and 136 patients were given patient information leaflets and package inserts, respectively. Most respondents were female (65.6%), over half had a degree (56.2%). Patients reading the patient information leaflets had slightly higher overall safety knowledge scores than those reading the package inserts (5.88 ± 2.25 vs 5.25 ± 1.84, p=0.01). Using the Consumer Information Rating Form, the patient information leaflets were given significantly higher scores compared to the package inserts for comprehensibility (19.34±3.92 vs 17.32±3.52, p<0.001) and design quality (29.25 ± 5.00 vs 23.81 ± 5.16, p<0.001). After reading the leaflets, patients receiving the patient information leaflets had significantly higher satisfaction with the information provided (p=0.003). In contrast, those receiving the package inserts rated the risks of omeprazole higher (p=0.007). CONCLUSION: Demonstrable differences were found from the patient perspective between a package insert and a patient information leaflet for the same medicine, mostly in favour of patient information leaflets. Medicine safety knowledge after reading PI and PIL was similar. However, receiving package inserts provided higher perceived risks from taking the medicine.
format Online
Article
Text
id pubmed-10064870
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-100648702023-04-01 Evaluation of Medicine Information Leaflets for Omeprazole, Safety Knowledge, and Perceptions of Taking the Medication in Thailand Wongtaweepkij, Kamonphat Sup-adulchai, Nutchwarang Chanachoat, Jirath Krska, Janet Jarernsiripornkul, Narumol Patient Prefer Adherence Original Research PURPOSE: This study aimed to compare package inserts and patient information leaflets for omeprazole in terms of the quality of and satisfaction with the written medicine information, medication safety knowledge, and perceived benefits and risks. PATIENTS AND METHODS: A cross-sectional, comparative study was conducted at a university hospital in Thailand. Outpatients visiting the pharmacy departments prescribed omeprazole were randomly selected to receive either a package insert or a patient information leaflet. Medication safety knowledge was measured using a set of eight questions. The quality of the written medicine information was measured by the Consumer Information Rating Form. Perceived benefits and risks of the medication were rated using a visual analog scale. Linear regression was used to determine factors associated with perceived benefits and risks. RESULTS: Of the 645 patients, 293 agreed to answer the questionnaire. 157 and 136 patients were given patient information leaflets and package inserts, respectively. Most respondents were female (65.6%), over half had a degree (56.2%). Patients reading the patient information leaflets had slightly higher overall safety knowledge scores than those reading the package inserts (5.88 ± 2.25 vs 5.25 ± 1.84, p=0.01). Using the Consumer Information Rating Form, the patient information leaflets were given significantly higher scores compared to the package inserts for comprehensibility (19.34±3.92 vs 17.32±3.52, p<0.001) and design quality (29.25 ± 5.00 vs 23.81 ± 5.16, p<0.001). After reading the leaflets, patients receiving the patient information leaflets had significantly higher satisfaction with the information provided (p=0.003). In contrast, those receiving the package inserts rated the risks of omeprazole higher (p=0.007). CONCLUSION: Demonstrable differences were found from the patient perspective between a package insert and a patient information leaflet for the same medicine, mostly in favour of patient information leaflets. Medicine safety knowledge after reading PI and PIL was similar. However, receiving package inserts provided higher perceived risks from taking the medicine. Dove 2023-03-27 /pmc/articles/PMC10064870/ /pubmed/37009429 http://dx.doi.org/10.2147/PPA.S397557 Text en © 2023 Wongtaweepkij et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wongtaweepkij, Kamonphat
Sup-adulchai, Nutchwarang
Chanachoat, Jirath
Krska, Janet
Jarernsiripornkul, Narumol
Evaluation of Medicine Information Leaflets for Omeprazole, Safety Knowledge, and Perceptions of Taking the Medication in Thailand
title Evaluation of Medicine Information Leaflets for Omeprazole, Safety Knowledge, and Perceptions of Taking the Medication in Thailand
title_full Evaluation of Medicine Information Leaflets for Omeprazole, Safety Knowledge, and Perceptions of Taking the Medication in Thailand
title_fullStr Evaluation of Medicine Information Leaflets for Omeprazole, Safety Knowledge, and Perceptions of Taking the Medication in Thailand
title_full_unstemmed Evaluation of Medicine Information Leaflets for Omeprazole, Safety Knowledge, and Perceptions of Taking the Medication in Thailand
title_short Evaluation of Medicine Information Leaflets for Omeprazole, Safety Knowledge, and Perceptions of Taking the Medication in Thailand
title_sort evaluation of medicine information leaflets for omeprazole, safety knowledge, and perceptions of taking the medication in thailand
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064870/
https://www.ncbi.nlm.nih.gov/pubmed/37009429
http://dx.doi.org/10.2147/PPA.S397557
work_keys_str_mv AT wongtaweepkijkamonphat evaluationofmedicineinformationleafletsforomeprazolesafetyknowledgeandperceptionsoftakingthemedicationinthailand
AT supadulchainutchwarang evaluationofmedicineinformationleafletsforomeprazolesafetyknowledgeandperceptionsoftakingthemedicationinthailand
AT chanachoatjirath evaluationofmedicineinformationleafletsforomeprazolesafetyknowledgeandperceptionsoftakingthemedicationinthailand
AT krskajanet evaluationofmedicineinformationleafletsforomeprazolesafetyknowledgeandperceptionsoftakingthemedicationinthailand
AT jarernsiripornkulnarumol evaluationofmedicineinformationleafletsforomeprazolesafetyknowledgeandperceptionsoftakingthemedicationinthailand